Feature Channels:

Vaccines

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Science

Channels:

Scientists Jump Hurdle in HIV Vaccine Design

cladeC_structure.jpg

Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design.

Medicine

Channels:

Alzheimer’s, Research, Brain, Ut Southwestern, O’Donnell

DNA Vaccine Protects Against Toxic Proteins Linked to Alzheimer’s

rosenberg-roger-body.jpg

A new DNA vaccine when delivered to the skin prompts an immune response that produces antibodies to protect against toxic proteins associated with Alzheimer’s disease – without triggering severe brain swelling that earlier antibody treatments caused in some patients.

Medicine

Channels:

New Bladder Cancer Drug, Skin Cancer Facts, Advanced Stage Colorectal Cancer, and More in the Cancer News Source

Click here to go directly to the Cancer News Source

Medicine

Channels:

Ebola, Viruses, Virus, Vaccines, Antibodies, Epidemic, Research, Global Health, Disease, Prevention, Infection, Infectious Diseases

Researchers Discover First Human Antibodies That Work Against All Ebolaviruses

After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first natural human antibodies that can neutralize and protect animals against all three major disease-causing ebolaviruses. The findings, published online today in the journal Cell, could lead to the first broadly effective ebolavirus therapies and vaccines.

Medicine

Channels:

Ebola, New Drugs, Vaccines, therapeutics against disease

ASU’s Arntzen on Ebola Outbreak: Promising Drugs Lead the Charge on a Devastating Disease

CharlesArntzenASU.jpg

Medicine

Channels:

Researchers Apply New Immune Technologies in Search of Mono Vaccine

ScreenShot2017-05-16at12.15.03PM.png

With a recent $1.8 million, five-year grant from the National Institutes of Health, Brandon DeKosky’s lab is using high-throughput techniques to analyze the behavior of B cells in the body.

Medicine

Channels:

flu, Vaccine, Pregnancy, Premature Birth, Low Birth Weight, Infection, Nepal, The Lancet, The Lancet Infectious Diseaes, Infectious Diseases, Pediatrics

Year-Round Flu Vaccinations Promote Healthier Infants in Subtropics

Steinhoff_LancetID_VillageSurveyEXT.jpg

Vaccinating pregnant mothers year-round against flu in the resource-challenged region of subtropical Nepal reduced infant flu virus infection rates by an average of 30 percent, increased birth weights by 15 percent and resulted in babies having less influenza, according to a study published in The Lancet Infectious Diseases. An international research team says expanding year-round flu vaccinations during pregnancy would also benefit children in other tropical and subtropical parts of the world.

Medicine

Channels:

Cancer, free C3d, Cancer Vaccine, Immunotherapy

Free C3d Regulates Immune Checkpoint Blockade and Enhances Anti-Tumor Immunity

TumorFigureCascalho.jpg

Researchers have found a protein that stops cancer’s ability to prevent the immune system from destroying cancer cells. The protein, free C3d, has the potential to be developed into a cancer vaccine and a cancer treatment.

Medicine

Channels:

Vaccines, The Wistar Institute, Infectious Disease, Computational Biology, Biophysics, LASV, Lassa virus

The Wistar Institute Appoints Daniel W. Kulp, Ph.D., as Associate Professor in the Vaccine Center and Translational Tumor Immunology Program

DanKulp.jpg

The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of Daniel W. Kulp, Ph.D., as associate professor in the Vaccine Center and the Translational Tumor Immunology Program.

Medicine

Channels:

Cancer, Tumor, Simmons Comprehensive Cancer Center, Ut Southwestern, Research

Nanoparticle Vaccine Shows Potential as Immunotherapy to Fight Multiple Cancer Types

DSC_0054a5x7group.jpeg

Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types.







Chat now!